California Public Employees Retirement System
NRIX icon

California Public Employees Retirement System’s Nurix Therapeutics NRIX Stock Holding History

California Public Employees Retirement System’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-22,600
Closed -$703K – 2449
2021
Q1 		$703K Sell
22,600
-2,075
-8% -$78.5K ﹤0.01% 2748
2020
Q4 		$811K Sell
24,675
-500
-2% -$16.6K ﹤0.01% 2622
2020
Q3 		$879K Buy
+25,175
New +$634K ﹤0.01% 2370

Other funds holding NRIX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

California Public Employees Retirement System's NRIX Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Nurix Therapeutics (NRIX) in Q2 2021, closing a stake of 22,600 shares — an estimated $703K sold.

California Public Employees Retirement System first reported a position in NRIX in Q3 2020 and held it in 3 quarters. The position peaked at $879K in Q3 2020. 103 funds tracked by Wall St. Rank hold NRIX as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Nurix Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 22,600 Nurix Therapeutics shares in Q2 2021, an estimated $703K.
  • California Public Employees Retirement System first reported a position in Nurix Therapeutics in Q3 2020 and held it in 3 quarters.
  • California Public Employees Retirement System's Nurix Therapeutics position peaked at $879K in Q3 2020.
  • 103 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.